Announcements

  • May 12, 2011

    For a description of NIA’s mission and priorities please see: NIA's listing of Priorities and Programs

    Budget Data: NIH (including NIA) received a full year continuing resolution budget for FY 2011 at approximately 1% below the FY 2010 level. A detailed mechanism table showing allocations through FY2010 is available at: NIA's FY 2010 Budget Mechanism Table

    Funding

    Strategy: NIA’s effort to increase the number of competing awards made during this cycle of minimal to negative growth includes limiting the numbers of large applications accepted for review and the numbers awarded (a large application requests direct costs of $500,000 or more in any single year). NIA program divisions have been assigned a limited annual budget for accepting large applications. NIA continues to make competing RPG awards at an average reduction of 18% below the study-section recommended amount.

    Guidelines

    Competing awards:

    RPG applications requesting less than $500,000 (direct costs) in all requested years: These applications will be paid through the 11th percentile with the following exceptions. Early Stage Investigator (ESI)-eligible R01 applications will be paid through the 16th percentile. Other new investigator eligible R01 applications will be paid through the 14th percentile.

    RPG applications requesting at least $500,000 (direct costs) in one or more years: These applications will be paid through the 8th percentile with the following exceptions. If an application is ESI-eligible these R01 applications will be paid through the 13th percentile. Other R01 new investigator applications will be paid through the 11th percentile.

    Non-Competing awards:

    NIA will follow NIH policy on noncompeting awards and post further information to this site when it becomes available.

    NIA is also continuing to review balances in noncompeting awards and adjusting or delaying award of the next noncompeting or competing year when appropriate.

    Non-RPG mechanisms:

    NIA is following NIH policy on remaining lines including centers, small business, training, scientific meetings, resource-related, and career development awards.

    NIA will review RPG balances in July and any update to the funding lines will be announced at that time.

    Note on Ranking of RPG applications reviewed at NIA:

    Although the bulk of RPG applications (other than those submitted in response to RFAs and a few PARs) are reviewed at CSR and given percentile ranks based on the panel in which they were reviewed, program project applications and some multi-site cooperative agreement and research grant (R01) applications are reviewed at NIA. Beginning May 2011, no percentile rank appears on the summary statement for these applications. Instead, for funding consideration, they are ranked against other NIA-reviewed RPG applications from the current and recent preceding rounds. This policy for ranking P01 and other non-RPG applications reviewed at NIA became effective for all FY 2011 and succeeding year applications.

  • August 3, 2011

    The NIA announces the reissuance of a Funding Opportunity Announcement (FOA) that provides dissertation awards in all areas of research within NIA’s strategic priorities to increase diversity of the scientific research workforce engaged in research on aging and aging-related health conditions. See more information »

  • August 9, 2011

    OppNet is a trans-NIH initiative to expand the agency's funding of basic behavioral and social sciences research (b-BSSR). For more information and a link to funding announcements, please visit the OppNet web site.

  • August 9, 2011

    The NIH Common Fund supports the Science of Behavior Change program to improve our understanding of human behavior change across a broad range of health-related behaviors.

  • August 9, 2011

    The NIH Common Fund supports a health economics program to stimulate research of value for Health Care Reform.

  • December 6, 2011

    Investigators interested in using the Health and Retirement Study genotype data can find further information on the HRS website. Genotype and limited phenotype data will be available via the dbGaP application process. If investigators are interested in linking the genotype data with other HRS measures not in dbGaP they will be able to apply for access from HRS directly. A National Academy of Sciences Expert meeting was held to discuss the use of HRS GWA data.

  • April 21, 2010

    Rapamycin joins the aging fray: maybe Ponce de Leon visited Rapa Nui, not Florida. Sierra, F., J. Gerontol A Biol Sci Med Sci. 65:577-579, 2010.

  • February 19, 2009

    Biology of Aging Summit Report. Sierra, F., J Gerontol A Biol Sci Med Sci. 64:155-6, 2009.

    In September 2008, the Division of Aging Biology (DAB) of the National Institute on Aging (NIA) held a summit to assess the current state of research in the field of biogerontology and to attempt to delineate goals for the future. The 3-day meeting, held in Gaithersburg, Maryland, brought together a group of 40 well-respected scientists, from both within and outside the field, with sufficient expertise to address the global issues at hand. The main part of the meeting was a series of 15 sessions (with groups of three to four sessions in parallel), where rather than the usual presentation and discussion of data from individual speakers, free discussion of ideas was encouraged, partially driven by a set of questions chosen in advance by the session chairs and DAB. The subjects of discussion, as well as participants, were chosen by a steering committee chosen by DAB staff. The topics discussed are reflected in the accompanying articles in this issue of the Journals of Gerontology, which delineate the gaps and opportunities identified within various research areas, and summarize the collective conclusions reached by each of the discussion groups. As a way of introduction, it is relevant to indicate some (new) areas that came up repeatedly during the sessions and pervaded many of the discussions.

     

     

  • November 20, 2009

    The longevity dividend: why invest in basic aging research? Warner, H. and Sierra, F., Can J Aging. 28:391-398; (in French: 395-398), 2009.

  • January 1, 2011

    Acute kidney injury in older adults. Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel PL, Molitoris BA, Murthy M, O'Hare AM, Schmader KE, High KP. J Am Soc Nephrol. 22:28-38, 2011.

Pages